Aouel Shaaban 1429

3rd August 2008 OFFICIAL GAZETTE OF THE REPUBLIC OF ALGERIA NO. 44 3

ACTS

The Act No. 08-13 of 17 Rajab 1429 corresponding to 20th incompatibilities and obligations attached to certain jobs and
July 2008 amending and supplementing the Act No. functions ;
85-05 of 16th February 1985 concerning the Following the opinion of Council of State ;
protection and promotion of health.
———— Following adoption by the Parliament;

The president of the Republic,

Promulgates the act which reads as follows :
Considering the Constitution, in particular Articles 54, 119,
122 and 126;
Article 1 — This Act to amend and supplement certain
Having regard to the Ordinance No. 66-155 of 8th June, provisions of Act No. 85-05 of 16th February 1985 concerning
1966, amended and supplemented, concerning the Code of the protection and promotion of health.
Criminal Procedure ;
Art. 2. — The heading of Title V of the Act No. 85-05 of
Having regard to the Ordinance No. 66-156 of 8th June, 16th February 1985, mentioned above, is amended as follows
1966, modified and supplemented, concerning the Penal code :
; TITLE V
PHARMACEUTICAL PRODUCTS
Having regard to the Act No. 83-11 of 2nd July 1983 AND MEDICAL DEVICES
amended and supplemented, concerning the social insurance ;
Art. 3. — The provisions of Article 169 of the Act No. 85-
Having regard to the Act No. 85-05 of 16th February 1985, 05 of 16th February 1985, mentioned above, are amended and
amended and supplemented, concerning the protection and supplemented as follows :
promotion of health;
Having regard to the Act No. 89-02 of 7th February 1989 «Art. 169. — by pharmaceutical means, within the meaning
concerning the general rules of consumer protection; of this Act :
— the medications ;
Having regard to the Ordinance No. 95-27 of 8 Shabaan
1416 corresponding to 30th December 1995 concerning the — the biological reagents ;
Finance Act for 1996 ;
— the pharmacopoeial chemical products ;
Having regard to the Act No. 2000-06 of 27 Ramadhan 1421
corresponding to 23rd December 2000 related to the Finance — the galenical products ;
Act for 2001 ; — the dressing objects ;
Having regard to the Act No. 01-21 of 7 Chaoual 1422 — the radionuclide which is the radioactive isotope ;
corresponding to 22nd December 2001 concerning Finance
Act for 2002 ; — the kit which is any preparation derived from the
reconstitution or combination with radionuclides in the final
Having regard to the Act No. 02-11 of 20 Chaoual 1423 drug product;
corresponding to 24th December 2002 concerning the Finance
— the precursor which is allowing radionuclide radioactive
Act for 2003 ; labeling of another substance prior to administration to the
Having regard to the Ordinance No. 03-03 of 19 Joumada humans ;
El Oula 1424 corresponding to 19th July, 2003, amended and — All other products necessary for human medicine».
supplemented on the competition ;
Having regard to the Ordinance 03-07 du 19 Joumada El- Art. 4. — The provisions of Article 170 of Act No. 85-05 of
16th February 1985, mentioned above, are amended and
Oula 1424 corresponding to 19th July 2003 relating to patents
supplemented as follows :
of invention ;
Having regard to the Act No. 04-08 of 27 Joumada Ethania «Art. 170. — The term medication is as defined in this Act
1425 corresponding to 14th August 2004 concerning the :
conditions for conducting business activities ; — Any substance or composition presented as having
Having regard to the Act No. 04-18 of 13 Dhou El Kaada curative or preventive properties in respect of human and
1425 corresponding to 25th December 2004 related to the animal diseases, and all products that can be administered to
prevention and suppression of illicit use and trafficking of humans or animals with a view to making a medical diagnosis
or to restoring, correcting and modifying organic functions ;
narcotic drugs and psychotropic substances;

Having regard to the Ordinance No. 07-01 of 11 Safar 1428

corresponding to 1st March 2007 relating to specific
Aouel Shaaban1429
4 OFFICIAL GAZETTE OF THE REPUBLIC OF ALGERIA NO. 44 3rd August 2008

— any compounding of extemporaneous preparation in with the exception of human origin products or other
pharmacies pursuant to a medical prescription ; article used alone or in combination, together with any
— any hospital preparation prepared on prescription accessories or software for its operation for use in humans
and according to the prescriptions of a pharmacopoeia for purposes :
because of the lack of proprietary or generic drug available
— diagnosis, prevention, monitoring, treatment or
or suitable, in the pharmacy of a health facility and are to
be delivered to one or more patients ; alleviation of disease or compensation for an injury or
handicap,
— any officinal drug preparation prepared in pharmacy
— study, replacement or modification of the anatomy
according to indications of pharmacopoeia or national
formulary drugs and intended to be delivered directly to or of a physiological process,
the patient ; — the control of medically assisted procreation «.
— any divided officinal product defined as any single Art. 7. — The provisions of Title V of the Act No. 85-05
drug, any chemical or stable preparation specified in the
of 16th February 1985, mentioned above, are complemented
pharmacopoeia, prepared in advance by a pharmaceutical
company that ensures its division as well as the pharmacy by a chapter 1a entitled "The National Agency of
or hospital pharmacy ; Pharmaceuticals for use in human medicine" containing
items from 173-1 to 173-10 worded as follows :
— any medicinal product prepared in advance,
presented in a special pack and characterized by a special «Art. 173-1. —A national agency of pharmaceuticals has
name ; been created for use in human medicine, hereinafter
referred to as the "the agency”.
— any generic that has the same qualitative and
quantitative composition in active principle(s), the same The Agency is an independent administrative authority
pharmaceutical form without new indications and that is with legal personality and financial autonomy.
interchangeable with the reference product because of its
bioequivalence demonstrated by appropriate The organization and operation and the status of agency
bioavailability studies ; workers are set by regulation.
— any allergen is any product intended to identify or «Art 173-2. — It is created with the agency specialized
induce a specific acquired alteration in the immune
committees as mentioned below :
response to an allergenic agent ;
— any vaccine, toxin or serum that are any agent to be — the Board of Registration of drugs ;
administered to man in order to produce active or passive
— the registration committee for pharmaceuticals and
immunity or to diagnose the state of immunity ;
medical devices for use in human medicine ;
— any radiopharmaceutical product which is ready to
be administered to humans and which contains one or more — the supervisory committee of medical, scientific
radionuclides ; and advertising information ;
— any stable product derived from blood ; — the Price Study Committee on pharmaceuticals and
medical devices for use in human medicine «.
— any concentrated hemodialysis or peritoneal dialysis
solutes ; «Art. 173-3. — As part of the national policy on
— the medical gases «. pharmaceuticals for use in human medicine, the agency's
main tasks are :
Art. 5. — The provisions of Article 171 of the Act No.
85-05 of 16th February 1985, mentioned above, are — to ensure the promotion of production in the field of
amended and supplemented as follows : pharmaceuticals and medical devices for use in human
«Art 171. — The following are also related to drugs: medicine ;
—( without change) — to ensure the safety, efficacy, quality and control of
pharmaceutical products and medical devices for use in
— the dietary products containing non-food human medicine ;
substances conferring useful properties to human health,
— the genetically modified organisms or organisms
that have undergone an unnatural change in their initial
characteristics by adding or removing or replacing at least
one gene and used in healthcare, production of medicines
or vaccines «.
Art. 6. — The provisions of Article 173 of the Act No.
85-05 of 16th February 1985, mentioned above, are
amended as follows :

«Art. 173. A medical device is meant for the purposes of

this Act, any equipment, device, instrument or product,
Aouel Shaaban1429
3rd August 2008 JOURNAL OFFICIEL DE LA REPUBLIQUE ALGER1ENNE N° 44 5

— to ensure accessibility to pharmaceutical products — to suspend all testing, manufacture, preparation,

and medical devices for use in human medicine; importation, production, distribution, packaging, storage,
— to ensure market regulation of pharmaceuticals and placing on the market free of charge or the possession for
medical devices for use in human medicine ; sale or free distribution, advertising, use , delivery or
administration of a drug subject or not subject to
— to ensure compliance with laws and regulations registration where the product has or is suspected of
relating to pharmacy activities, pharmaceuticals and having, a danger to human health under normal conditions;
medical devices for use in human medicine.
— to advise on all matters related to pharmaceuticals
«Art. 173 4. As part of the general tasks laid down in
- —
and medical devices for use in human medicine as well as
Article 173-3 above, the agency is responsible for : the interest of any new product ;
— to participate and offer the parts involved in the
— drug registration and licensing of pharmaceuticals development of pharmaceutical sector development
and medical devices for use in human medicine ; strategies and policies ;
— the issuing of visas for the importation of — to issue an opinion on any draft legislative or
pharmaceutical products and medical devices for use in regulatory nature governing the field of pharmacy,
human medicine ; pharmaceutical products and medical devices for use in
human medicine and to make any proposal for improving
— to determine at the time of registration or approval in the normative system in force in the material ;
accordance with the provisions and procedures laid down
by legislation and regulations, the producer prices and — to establish an annual report to the Minister for
import respectively pharmaceuticals and medical devices, Health on the market situation of pharmaceuticals and
in use human medicine, after consulting the committee medical devices for use in human medicine, and its
evolution ;
responsible for the study of price created with respect to
the agency ; — to establish an annual report of its activities that
address the Minister for Health.
— to participate in the development of the list of
pharmaceuticals for use in human medicine eligible for The agency develops and adopts its rules of procedure“.
reimbursement ;
«Art. 173 5. The agency's financial resources include :
- —

— to carry out the evaluations of the benefits and risks

associated with the use of pharmaceuticals and medical — the own resources, including from fees and taxes
related to the registration, licensing and advertising of
devices for use in human medicine ;
pharmaceuticals and medical devices for use in human
— to ensure the proper functioning of vigilance medicine ;
systems ;
— the revenues out of the services provided ;
— to take and / or the competent authorities to take the — the donations and legacies ;
necessary measures in case of risk to public health ;
— any other resources related to its activities «.
— to participate in expertise and of control of
pharmaceutical products and medical devices for use in
«Art. 173 6. The expenditure of the Agency includes :
- —
human medicine within its jurisdiction ;
— the operating expenses ;
— to control advertising and to ensure a reliable
medical information on pharmaceutical products and — the capital (equipment) expenditure ;
medical devices for use in human medicine ; — any other expenses necessary to achieve its tasks «.
— to constitute a scientific and technical database «Art. 173 7. For the launch of operation of the agency,
- —

necessary for the fulfillment of its mission. It is addressed the Treasury makes available to it a repayable advance
to this end, all medical and scientific information ; enabling him to operate.
— to collect and evaluate information on drug abuse
and likely to be driven by psychoactive substances ;
— to undertake all studies, research, training programs
or information in the fields of its competence, and to
contribute to the promotion of scientific research in the
field of pharmaceuticals ;
Aouel Shaaban1429
6 OFFICIAL GAZETTE OF THE REPUBLIC OF ALGERIA NO. 44 3rd August 2008

The modalities of release and repayment of the advance

shall be determined by an agreement between the Public The procedures for establishing and updating national
Treasury and the agency. and hospital classifications are determined by regulations”.

“Art. 173-8. — The additional funds necessary for the «Art 175c. — The National Agency of Pharmaceuticals
agency to accomplish its missions, as appropriate, in the for use in human medicine can deliver, for a limited time,
general budget of the state and in accordance with the a temporary authorization for use of unregistered drugs in
established procedures”. Algeria when they are prescribed in the context of the
serious disease management and / or rare, for which there
“ Art. 173-9. — The accounting of the agency is required is no equivalent treatment in Algeria and for which there is
in the commercial form “. a strongly suspected therapeutic utility.
“Art. 173-10. — The financial control of the agency is The terms and conditions for granting temporary
provided by an external auditor”. authorization to use drugs cited in the paragraph above are
fixed by regulation”.
Art. 8. — The heading of Chapter II of Title of the Act
No. 85-05 of 16th February 1985, mentioned above, is Art. 12. — The provisions of Article 176 of the Act No.
amended as follows : 85-05 of 16th February 1985, mentioned above, are
amended as follows :
CHAPTER II
REGISTRATION, APPROVAL AND NATIONAL “Art. 176. — These can be imported or supplied to the
GAZETTEERS AND HOSPITALIERES public, on national territory, the registered or authorized
drugs and pharmaceuticals and medical devices approved
Art. 9. — The provisions of Article 174 of the Act No. for use in human medicine”.
85-05 of 16th February 1985, mentioned above, are
amended and supplemented as follows : Art. 13. — The provisions of Article 178 of the Act No.
85-05 of 16th February 1985, mentioned above, are
«Art. 174. — In order to protect or restore the health of amended as follows :
citizens, to ensure the implementation of programs and
campaigns to prevent, diagnose and treat patients and “Art. 178. — It is forbidden to experiment on humans,
protect the public against the use of unauthorized products, drugs, biologics and medical devices for use in human
medical practitioners do may prescribe and use that medicine without permission from the Minister for
registered medicinal and pharmaceutical products Health”.
registered in use in human medicine, appearing on national
classifications thereto or drugs having been a temporary Art. 14. — The heading of Chapter HI of Title V of the
authorization for use”. Act No. 85-05 of 16th February 1985, mentioned above, is
amended as follows:
CHAPITER III
Art. 10. — The provisions of Article 175 of the Act No. ACQUISITION OF MEDICINES
85-05 of 16th February 1985, mentioned above, are
AND MEDICAL DEVICES
amended as follows :
“Art. 175. — Any drug use in human medicine ready, Art. 15. — The provisions of Article 180 of the Act No.
industrially manufactured, imported or exported must be, 85-05 of 16th February 1985, mentioned above, are
before being put on the market with or without charge, a amended and supplemented as follows :
registration decision issued by the Agency national
pharmaceuticals for use in human medicine provided for in “Art. 180. — The drugs for hospital usage as listed in
Article 173-1 above the advice of the Board of registration schedules provided for in Article 175a above and
of medicines created from this agency. prescribed by medical practitioners in public hospitals,
The missions, composition, organization and functioning must be provided free inpatient or outpatient treated by
of the Board of Registration of drugs, registration these institutions”.
procedures for medicinal products for human medicine, the
conditions for the granting, renewal and withdrawal of the
decision registration and the conditions of assignment and
transfer of registration are determined by the regulation”.

Art. 11. — The provisions of the Act No. 85-05 of 16th

February 1985, mentioned above, are supplemented by
Articles 175a and 175b worded as follows :
“Art. 175a. — The national classifications of
pharmaceuticals for use in human medicine are collections
of products registered or approved.
The classifications of hospital-pharmaceuticals are
derived from national classifications set out in paragraph
above.
Aouel Shaaban1429
3rd August 2008 JOURNAL OFFICIEL DE LA REPUBLIQUE ALGER1ENNE N° 44 7

Art. 16. — The provisions of Article 184 of the Act No. Art. 20. — The provisions of Article 187 of the Act No.
85-05 of 16th February 1985, mentioned above, are 85-05 of 16th February 1985, mentioned above, are
amended and supplemented as follows : amended as follows :

«Art. 184. — The manufacture, import and export of “Art. 187. — The officinal formulas and extemporaneous
pharmaceuticals for use in human medicine must be and hospital preparations are made in pharmacies and
carried out by public institutions and pharmaceutical hospital pharmacies ".
approved private pharmaceutical establishments, with the
exception of preparations under Article 187 below. Art. 21. — The provisions of Article 188 of the Act No.
85-05 of 16th February 1985, mentioned above, are
The technical management of manufacturing plants, as amended and supplemented as follows :
well as import and export of pharmaceuticals for use in
human medicine, should be provided by a pharmacist “ Art. 188. — The retail distribution of pharmaceutical
technical director. products for use in human medicine is provided by
pharmacies under the responsibility of a pharmacist.
The manufacture, import, distribution and export of
medical devices for use in human medicine, as defined in
Section 173 of this Act shall be carried out by public For private pharmacy dispensaries, the pharmacists must
institutions and by approved private institutions. be the sole owner and sole manager of the business of the
pharmacy dispensary.
The conditions for approval of private establishments
mentioned in paragraphs 1 and 3 above are laid down by The pharmacy department must have as main activity the
regulation”. distribution of pharmaceutical products for use in human
medicine. They can, incidentally, ensure the distribution of
Art. 17. — The provisions of the Act No. 85-05 of 16th pharmaceutical products”.
February 1985, mentioned above, are complemented by
Article 184a reads as follows : Art. 22. — The provisions of Article 189 of the Act No.
85-05 of 16th February 1985, mentioned above, are
«Art. 184a. — The preparation, import and distribution amended and supplemented as follows :
of attenuated or not, therapeutic sera, modified toxins or
not, and in general, the various products of microbial “Art. 189. — The dispensing chemists can provide
origin, which may serve, in any form, diagnosis, certain biological analyzes on terms and conditions
prophylaxis or therapeutic, as well as allergens, are established by regulation”.
entrusted to public institutions on terms and conditions
established by regulation”. Art. 23. — The provisions of Article 193 of the Act No.
85-05 of 16th February 1985, mentioned above, are
Art. 18. — The provisions of Article 185 of the Act No. amended and supplemented as follows :
85-05 of 16th February 1985, mentioned above, are
amended as follows : «Art. 193. — Certain pharmaceuticals and medical
“Art. 185. — The binding conditions of good devices for use in human medicine should be, before being
placed on the market, or without consideration, an
manufacturing practices for pharmaceutical products and
approval decision of the National Agency of
medical devices for use in human medicine are set by the
Pharmaceuticals for use human medicine the advice of the
Minister for Health”. registration committee pharmaceuticals and medical
Art. 19. — The provisions of Article 186 of the Act No. devices for use in human medicine, created with the
85-05 of 16th February 1985, mentioned above, are agency.
amended and supplemented as follows :
The list of pharmaceuticals for use in human medicine
« Art. 186. — The wholesale distribution of subject to approval, quoted in paragraph above, is set by
pharmaceuticals for use in human medicine is provided the National Agency of Pharmaceuticals for use in human
exclusively by public establishments and licensed private medicine.
institutions.
The missions, composition, organization and functioning
The technical management of the distribution facilities of the approval committee and approval procedures of
wholesale of pharmaceuticals for use in human medicine these pharmaceuticals and medical devices for use in
is provided by a pharmacist technical director”. human medicine as well as the conditions for granting,
renewal and withdrawal of the approval decision are set by
the regulation”.
Aouel Shaaban1429
8 OFFICIAL GAZETTE OF THE REPUBLIC OF ALGERIA NO. 44 3rd August 2008

Art. 24. — The provisions of Title V of the Act No. 85- contents of the medical and scientific information and
05 of 16th February 1985, mentioned above, are advertising, organization and control are defined by the
complemented by a chapter VIa, entitled "Control and regulations”.
vigilance" containing articles 193a, 193b and 193c read as
follows : Art. 26. — The provisions of Article 211 of the Act No.
85-05 of 16th February 1985, mentioned above, are
«Art. 193a. — The pharmaceuticals and medical devices amended as follows :
for use in human medicine are subject to quality control and
compliance in accordance with the laws and regulations “. “Art. 211. — .................. (without change) ...................
«Art. 193 ter. — Any pharmaceutical product ready for The rates for services performed in private health
use as well as medical devices, for use in human medicine facilities may be cap-subject to conditions laid down by
can be placed on the market if they have not been certified regulation.
and inspected prior compliance with elements of the
registration dossier or approval”.
(the remainder unchanged) .................... “.
«Art. 193c. — The quality check, expertise, vigil,
including pharmacovigilance, medical device, blood safety Art. 27. — The provisions of Chapter II of Title VIII of
and toxicity monitoring of pharmaceutical products and the Act No. 85-05 of 16 February 1985, mentioned above,
medical devices for use in human medicine, are provided are modified, supplemented and written as follows :
by the relevant institutions in the matter under legislation
and regulations.
CHAPITER II
The establishments listed in the paragraph above are
assisting the National Agency of Pharmaceuticals for use CRIMINAL PROVISIONS FOR
in human medicine «. PHARMACEUTICAL AND MEDICAL DEVICES

Art. 25. — The provisions of Chapter VII of Title V of the

Act No. 85-05 of 16th February 1985, mentioned above, are “Art. 260. — There is a punishment with imprisonment
modified, supplemented and written as follows : of six (6) months to two (2) years and a fine of 20,000 DA
to 50,000 DA to a person who violates the provisions
CHAPITER VII relating to artificial radionuclides”.

MEDICAL AND SCIENTIFIC INFORMATION ” Art. 261. — There is a punishment with imprisonment
AND ADVERTISING of six (6) months to two (2) years and a fine of 10,000 DA
to 50,000 DA who violates the provisions related to
“Art. 194. — The medical and scientific information on species that can be used in the manufacture of alcoholic
pharmaceutical products and medical devices for use in beverages”.
human medicine is mandatory. It should be accurate,
auditable and compliant to the latest data from the medical “Art. 262. — There is a punishment of penalties
and scientific research at the time of its broadcasting. prescribed in the Penal Code any person who contravenes
the provisions on abortion”.
The medical and scientific information and advertising
on pharmaceutical products and medical devices for use in ”Art. 263. — There is a punishment with imprisonment
human medicine regularly registered or approved are made of one (1) to three (3) years and a fine of 500,000 DA to
by manufacturers and other specialist operator in medical 1,000,000 DA, the persons who are engaged in for profit,
promotion. trade of human blood, its plasma and their derivatives”.
The National Agency of pharmaceuticals may allow
advertising on certain pharmaceuticals and medical devices “Art. 264. — There is a punishment of with
for use in human medicine, regularly registered or licensed imprisonment of one (1) to three (3) years and a fine of
and not eligible for reimbursement. 500 000 DA to DA 1,000,000, whoever contravenes the
provisions relating to information on pharmaceutical
Any advertising action for pharmaceuticals and medical
products and medical devices in use in human medicine”.
devices for use in human medicine, quoted in paragraph
above, shall be submitted in advance to an advertising visa «Art. 265. — There is punishment of with imprisonment
of the National Agency of Pharmaceuticals for use of of two (2) to five (5) years and a fine of 500,000 DA to
human medicine, after consulting the committee 1,000,000 DA, any person who violates the provisions on
responsible for monitoring the medical and scientific the advertising of pharmaceuticals and medical devices, in
information and advertising agency created with this use for human medicine.
agency.

The missions, composition, organization and

functioning of the Committee monitoring the medical and
scientific information and advertising, as well as the
Aouel Shaaban1429
3rd August 2008 OFFICIAL GAZETTE OF THE REPUBLIC OF ALGERIA NO. 44 9

“Art 265b. — There is a punishment with imprisonment Act No. 08-14 of 17 Rajab 1429 corresponding to 20th
of two (2) to five (5) years and a fine of 1,000,000 DA to July 2008 amending and supplementing the Act
5,000,000 DA person who violates the provisions on No. 90-30 of 1st December 1990 of the public land
registration of drugs and the registration of law in force.
pharmaceuticals and medical devices for use in human
medicine”. The president of the Republic,
“ Art. 265c. — There is a punishment with imprisonment Considering the Constitution, in particular Articles 17,
of two (2) to five (5) years and a fine of 5,000,000 DA to 18, 119, 120, 122 and 126 ;
10,000,000 DA, any person who violates the provisions on
the import, export and control of pharmaceutical products Having regard to the Ordinance No. 76-80 of 23rd
and medical devices for use in human medicine”. October 1976, amended and supplemented, related to the
maritime code ;
“Art. 265d. — There is a punishment with imprisonment
of two (2) to five (5) years and a fine of 5,000,000 DA to Having regard to the Act No. 84-11 of 9th June 1984,
10,000,000 DA, whoever contravenes the provisions amended and supplemented, bearing the family code ;
relating to the manufacture and wholesale distribution of Having regard to the Act No. 90-30 of 1st December
pharmaceuticals and medical devices, for use in human 1990 concerned with public land law in force ;
medicine”.
Having regard to the Act No. 90-35 of 25th December
“Art. 265(vi) — There is a punishment with 1990 related to the police, security, safety, use and
imprisonment of six (6) months to two (2) years and a fine conservation in the use of rail transport ;
of 500,000 DA to 1,000,000 DA, any person who violates
the provisions on the retail distribution of pharmaceutical Having regard to the Act No. 91-11 of 27th AApril 1991,
products and medical devices in use in human medicine”. completed laying down general rules related to the
expropriation of the public interest ;
«Art. 265(vii) — There is a punishment with
Having regard to the Ordinance No. 96-02 of 19th
imprisonment of two (2) to five (5) years and a fine of
Shabaan 1416 corresponding to 10th January 1996 related
5,000,000 DA to 10,000,000 DA, any person who violates
to the organization of the profession of auctioneer ;
the provisions on experimentation on humans, drugs,
biological products and medical devices for use in human Having regard to the Act No. 98-04 of 20 Safar 1419
medicine”. corresponding to 15th June 1998 related to the protection of
cultural heritage ;
« Art. 265(viii) — There is a punishment to the legal
person who committed one of the offenses listed above, to Having regard to the Act No. 98-06 of 3 Rabie El Aouel 1419
a fine equivalent to five (5) times the maximum for the corresponding to 27th June 1998, as amended and supplemented,
individual”. establishing the general rules on civil aviation ;
«Art. 265(ix) — One or more additional penalties under Having regard to the Act No. 2000-03 of 5 Joumada El
the Penal Code, anyone who commits any of the offenses Oula 1421 corresponding to 5th August 2000 laying down
listed above may also be punished”. general rules for the post and telecommunications ;

Art. 28. — The support structures, currently, the tasks Having regard to the Act No. 01-10 of 11 Rabie Ethani
assigned to the National Agency of Pharmaceuticals for 1422 corresponding to 3rd July 2001, amended and
use in human medicine, under the provisions of this Act, supplemented, the mining law ;
continue to shoulder these tasks until the establishment of Having regard to the Act No. 01-11 of 11 Rabie Ethani
the said agency. 1422 corresponding to 3rd July 2001 related to fisheries
Art. 29. — Any contrary provisions in particular Articles and aquaculture ;
172 and 177 of the Act No. 85-05 of 16th February 1985, Having regard to the Act No. 01-13 of 17 Joumada El
mentioned above, are repealed. Oula 1422 corresponding to 7th August 2001 related to the
orientation and organization of land transport ;
Art. 30. — This law shall be published in the Official
Journal of the Algerian Democratic and Popular Republic. Having regard to the Ordinance No. 01-03 of Aouel
Joumada Ethania 1422 corresponding to 20th August 2001,
Drafted in Algiers, on 17 Rajab 1429 corresponding to amended and supplemented, on the development of
20th July, 2008. investment ;

Abdelaziz BOUTEFLIKA. Having regard to the Ordinance No. 01-04 of Aouel

Joumada Ethania 1422 corresponding to 20th August 2001,
supplemented, regarding the organization, management and
privatization of public economic enterprises ;
Having regard to the Act No. 01-20 of 27 Ramadhan 1422
corresponding to 12th December 2001 on the management
and sustainable development of the territory ;